Who Owns Krystal Biotech Stock?
NASDAQ: KRYSHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
After hours: 331.61 0.00%
Ownership breakdown
- Held by institutions
- 102.44%
- Institutions (% of float)
- 114.66%
- Held by insiders
- 10.66%
- Institutional holders
- 575
- Institutions 89.3%
- Insiders 10.7%
- Public and other 0.0%
Who owns Krystal Biotech stock?
Institutional investors own about 102.4% of Krystal Biotech's shares, spread across 575 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 10.66% of KRYS.
The largest institutional holders are FMR, LLC (14.93%), Blackrock Inc. (14.13%) and Avoro Capital Advisors LLC (9.76%). Together, the top 10 institutions control 63.4% of shares outstanding. In their latest filings, 7 of the top 10 institutions increased their KRYS positions and 2 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of KRYS
| Institution | Shares | % Held | Change |
|---|---|---|---|
| FMR, LLC | 4.42M | 14.93% | +1.0% |
| Blackrock Inc. | 4.18M | 14.13% | +6.1% |
| Avoro Capital Advisors LLC | 2.89M | 9.76% | 0.0% |
| Vanguard Portfolio Management LLC | 1.57M | 5.32% | +8.1% |
| State Street Corporation | 1.35M | 4.56% | +2.8% |
| Vanguard Capital Management LLC | 1.24M | 4.19% | +6.5% |
| Soleus Capital Management, L.P. | 939.25K | 3.17% | -18.5% |
| Capital World Investors | 777.84K | 2.63% | -5.7% |
| Geode Capital Management, LLC | 698.99K | 2.36% | +8.5% |
| Price (T.Rowe) Associates Inc | 687.40K | 2.32% | +41.7% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of KRYS
| Fund | Shares | % Held |
|---|---|---|
| Fidelity Select Portfolios-Select Biotechnology Portfolio | 1.80M | 6.09% |
| iShares Trust-iShares Core S&P Mid-Cap ETF | 919.11K | 3.11% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 889.55K | 3.01% |
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund | 816.13K | 2.76% |
| SmallCap World Fund Inc | 752.24K | 2.54% |
| iShares Trust-iShares Russell 2000 ETF | 664.82K | 2.25% |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 642.49K | 2.17% |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund | 370.50K | 1.25% |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 335.92K | 1.13% |
| Manager Directed Portfolios-Hood River Small-Cap Growth Fund | 329.78K | 1.11% |
Frequently asked questions
Who is the largest shareholder of Krystal Biotech?
FMR, LLC is the largest institutional shareholder of KRYS, owning 14.93% of shares outstanding (4.42M shares) as of its latest 13F filing.
What percentage of Krystal Biotech is owned by institutions?
Institutions own about 102.4% of KRYS shares and 114.7% of the public float.
How much of Krystal Biotech do insiders own?
Insiders, such as officers and directors, own about 10.66% of KRYS shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.